Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02020239
Other study ID # Bham_CPW_PhysActIntervention
Secondary ID
Status Active, not recruiting
Phase N/A
First received December 12, 2013
Last updated October 27, 2016
Start date December 2013
Est. completion date December 2017

Study information

Verified date October 2016
Source University of Birmingham
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

The investigators goal is to optimise physical activity interventions to help previously inactive women improve their body shape and composition. Many people seeking to lose weight or improve body composition initiate an exercise programme. The most common recommendation of an exercise intervention for someone attempting to manage their weight, has been to 'prescribe' the recommended 150 minutes of exercise per week (World Health Organisation), often using one mode of exercise. An alternative approach might be to offer a portfolio of activities, from which the exerciser can pick and choose, to facilitate greater amounts of physical activity. The problem with this is how do you account for the different intensities of walking, washing the car, playing badminton, cycling, jogging, etc? In this study, the investigators will try to overcome this barrier by allocating a number of "physical activity points" to each activity. Using this physical activity points system, participants will be provided with a points target that they can meet using any combination of activities.

The investigators research aim is therefore to compare this points-based system against the traditional 5x30minute prescription (and sedentary control) for their ability to help previously inactive women to drop a dress size, increase fat burning, positively change their body composition and tone their tummy.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 60
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 25 Years to 50 Years
Eligibility Inclusion Criteria:

- Female

- Aged 25-50 years old

- Inactive (less than 150 minutes of moderate-intensity aerobic physical activity per week)

- BMI 25-35 kg/m2

- Good general health, as assessed by the School of Sport, Exercise and Rehabilitation Sciences' General Health Questionnaire

- Willing to strictly comply with all study procedures and restrictions

- Willing to participate, as demonstrated by voluntary written informed consent

Exclusion Criteria:

- Positive result from the urine sample pregnancy test

- Currently breast feeding

- Currently participating in another clinical trial deemed to potentially interfere with this study

- Current or recent (within the last 30 days) smoker

- Currently taking prescription or non-prescription medication that may interfere with metabolism (including beta-blockers, insulin, bronchodilators, anti-inflammatory agents, thyroxine and medication/supplements that in the opinion of the investigators may affect metabolism).

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Exercise


Locations

Country Name City State
United Kingdom University of Birmingham, School of Sport, Exercise and Rehabilitation Sciences Birmingham

Sponsors (2)

Lead Sponsor Collaborator
University of Birmingham Cereal Partners Worldwide

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Other Blood-borne markers of metabolic health 4 weeks, 12 weeks, 24 weeks No
Other Psychological measures relating to perceived body image 4 weeks, 12 weeks, 24 weeks No
Other Psychological measures of attitudes towards exercise and physical activity 4 weeks, 12 weeks, 24 weeks No
Primary Change in body composition (fat and fat-free mass in kg) 4 weeks, 12 weeks and 24 weeks No
Secondary Perceived body shape 4 weeks, 12 weeks and 24 weeks No
Secondary Maximal aerobic capacity 4 weeks, 12 weeks, 24 weeks No
Secondary Fat oxidation rates 4 weeks, 12 weeks and 24 weeks No
Secondary Body tone 4 weeks, 12 weeks, 24 weeks No
See also
  Status Clinical Trial Phase
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Terminated NCT03299881 - Safety and Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS)-Assisted Weight Loss N/A
Completed NCT02805478 - Fat-Associated Cardiovascular Organ Dysfunction
Active, not recruiting NCT02558920 - Meta-analyses of Food Sources of Fructose-Containing Sugars and Obesity
Completed NCT03759743 - Evaluate the Efficacy and Safety of LMT1-48 on Reducing Body Fat in Overweight Subject N/A
Completed NCT03610958 - Safety and Performance Evaluation of the Epitomee Device for Enhancing Satiety and Weight Loss. N/A
Completed NCT03678766 - CHARGE: Controlling Hunger and ReGulating Eating N/A
Completed NCT04430465 - Effects of Wholegrains on Children's Health (KORN) N/A
Completed NCT04117802 - Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome N/A
Completed NCT05376865 - Effects of Vitamin D Supplementation on Obesity, Inflammatory and Metabolic Markers N/A
Completed NCT03625427 - Effect of Palmitoleic Acid on C-reactive Protein N/A
Active, not recruiting NCT03435445 - Online Platform for Healthy Weight Loss (POEmaS) N/A
Enrolling by invitation NCT05576116 - Combined Bariatric Surgery and Pancreas After Kidney Transplantation for Type II Diabetics N/A
Recruiting NCT05249465 - Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention N/A
Active, not recruiting NCT06023095 - A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities Phase 1
Completed NCT03648892 - Brain Dopamine Function in Human Obesity Early Phase 1
Not yet recruiting NCT05751993 - Piloting a Reinforcement Learning Tool for Individually Tailoring Just-in-time Adaptive Interventions N/A
Recruiting NCT02887950 - Resistant Starch, Epigallocatechin Gallate and Chlorogenic Acid for Body Weight Loss in Menopause N/A
Terminated NCT02743598 - Liraglutide for HIV-associated Neurocognitive Disorder Phase 4
Terminated NCT02796144 - MEtformin and Lorcaserin for WeighT Loss in Schizophrenia Phase 4

External Links